MMRF genomics initiative update

The Multiple Myeloma Genomics Iniative is now underway! To date, the MMRC has accrued the first 60 untreated myeloma tissue samples and has transferred these tissues to its collaborators -- the Eli and Edythe L. Broad Institute of MIT and Harvard, and the Translational Genomics Research Institute.

This exciting genome-mapping program is comprised of several related research and discovery efforts that aim to determine what genes and molecular pathways play a role in the onset and progression of myeloma, learn how patients will respond to therapies, and identify new druggable targets for the disease. Taken together, these findings will lead to the development of better, more effective therapies for myeloma.

The success of Multiple Myeloma Genomic Initiative hinges on researchers' ability to study, analyze, and characterize a large number of untreated myeloma patient tissue samples in great detail. This kind of research has been made possible only recently with the development of the MMRC Tissue Bank.

If you are interested in contributing a tissue sample to the MMRC Tissue Bank, please contact Alicia Sabel-Hunt, RN, MMRC Program Manager, at sablehunt@themmrc.org